论文部分内容阅读
肿瘤药理研究中的蛋白SUMO化修饰
【机 构】
:
复旦大学药学院
【出 处】
:
2016医学科学前沿暨第四届个体化治疗与抗肿瘤药物研究新趋向研讨会
【发表日期】
:
2016年11期
其他文献
血管破坏剂(Vascular disrupting agents,VDAs)选择性靶向肿瘤血管内皮细胞破坏肿瘤血管,导致肿瘤中心大面积坏死,从而发挥显著的抗肿瘤作用,是一类有发展前景的抗肿瘤药
会议
胰腺癌(PDAC)是一种恶性程度极高并迅速致命的难治性恶性肿瘤,目前,吉西他滨仍为治疗PDAC 的一线化疗药物。本研究力图通过基因型表型的关联分析研究以确定与预测性吉西
会议
Modulating balance of synaptic and extrasynaptic NMDA receptors as strategy for Alzheimer disease dr
The unbalance between synaptic(GluN2A,mediating the protective pathway)and extra-synaptic NMDA receptors(NMDARs)(GluN2B,mediating the excitotoxic pathway)ha
Targeting PRMT5 confers elimination of chronic myelogenous leukemia stem cells in combination with i
Leukemia stem cells(LSCs)insensitive to imatinib are believed to be responsible for resistance to BCR-ABL tyrosine kinase inhibitors and relapse of chronic
会议
The emerging roles of microRNAs(miRs)have been deeply investigated in cancer.MiR-194 is deregulated in various cancers,whereas little is known about it in h
会议
Inflammation and dysregulation of immune response in Alzheimer disease,the drug target for the futur
It has been demonstrated that inflammation and dysregulation of immune response are involved in the pathogenesis of Alzheimer disease(AD).